Novel RCT With Treatment Based on Tumor Characteristics

Novel RCT With Treatment Based on Tumor Characteristics

All Tumors Included
"Our goal is to have 200 randomized patients," said lead author Christophe Le Tourneau, MD, head of the phase I program at the Institut Curie in Paris. "Although 40% of the 320 patients have a tumor for which targeted drugs are available, some are still on the chemotherapy that was started at the time of the biopsy; therefore, we will have to randomize them later."
"Because we are looking for an effect in different kinds of tumors, we have ruled out the inclusion of any particular type of tumor if this brings the number of randomized patients with this type to over 20% of the total," Dr. Le Tourneau said in a statement. "We have also allowed the inclusion of patients with rare tumors.".......